Membrane Expression Enhances Folding, Multimeric Structure Formation, and Immunogenicity of Viral Capsid Proteins

IF 3.8 2区 医学 Q2 CHEMISTRY, MEDICINAL
Junru Cui, Fangfeng Yuan, Jane Qin, Ju Hyeong Jeon, Dong Soo Yun, Tianlei Wang, Renhuan Xu, Hong Cao, Ashleigh A. Tungate, Christopher L. Netherton and Jianzhu Chen*, 
{"title":"Membrane Expression Enhances Folding, Multimeric Structure Formation, and Immunogenicity of Viral Capsid Proteins","authors":"Junru Cui,&nbsp;Fangfeng Yuan,&nbsp;Jane Qin,&nbsp;Ju Hyeong Jeon,&nbsp;Dong Soo Yun,&nbsp;Tianlei Wang,&nbsp;Renhuan Xu,&nbsp;Hong Cao,&nbsp;Ashleigh A. Tungate,&nbsp;Christopher L. Netherton and Jianzhu Chen*,&nbsp;","doi":"10.1021/acsinfecdis.5c00067","DOIUrl":null,"url":null,"abstract":"<p >Viral capsid proteins are widely explored for subunit vaccine development but are often hampered by their complexity of production and low immunogenicity. Here, we report a simple approach to overcoming these challenges by combining mRNA vaccine technology with protein engineering. Using African swine fever virus (ASFV) capsid proteins P72 and penton as models, we engineered them into membrane-bound and secreted forms and compared their immunogenicity to that of the native intracellular form in mice and pigs through mRNA vaccination. The membrane-bound and secreted P72 and penton folded into their native multimeric structure independent of the viral chaperone, therefore preserving their conformational epitopes. The membrane-bound P72 and penton also elicited significantly stronger antibody and T cell responses than their secreted or intracellular counterparts. Our study provides a simple approach to enhancing folding, multimeric structure formation, and immunogenicity of viral capsid proteins for ASFV subunit vaccine development and immunogenicity of intracellular proteins in general.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":"11 8","pages":"2104–2115"},"PeriodicalIF":3.8000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsinfecdis.5c00067","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Viral capsid proteins are widely explored for subunit vaccine development but are often hampered by their complexity of production and low immunogenicity. Here, we report a simple approach to overcoming these challenges by combining mRNA vaccine technology with protein engineering. Using African swine fever virus (ASFV) capsid proteins P72 and penton as models, we engineered them into membrane-bound and secreted forms and compared their immunogenicity to that of the native intracellular form in mice and pigs through mRNA vaccination. The membrane-bound and secreted P72 and penton folded into their native multimeric structure independent of the viral chaperone, therefore preserving their conformational epitopes. The membrane-bound P72 and penton also elicited significantly stronger antibody and T cell responses than their secreted or intracellular counterparts. Our study provides a simple approach to enhancing folding, multimeric structure formation, and immunogenicity of viral capsid proteins for ASFV subunit vaccine development and immunogenicity of intracellular proteins in general.

Abstract Image

膜表达增强病毒衣壳蛋白的折叠、多聚体结构形成和免疫原性。
病毒衣壳蛋白被广泛用于亚单位疫苗的开发,但由于其生产的复杂性和低免疫原性而受到阻碍。在这里,我们报告了一种通过将mRNA疫苗技术与蛋白质工程相结合来克服这些挑战的简单方法。以非洲猪瘟病毒(ASFV)衣壳蛋白P72和penton为模型,将它们设计成膜结合和分泌形式,并通过mRNA接种在小鼠和猪体内比较它们与细胞内天然形式的免疫原性。膜结合和分泌的P72和penton折叠成独立于病毒伴侣的天然多聚体结构,因此保留了它们的构象表位。膜结合的P72和penton也比它们分泌的或细胞内的对应物引起更强的抗体和T细胞反应。我们的研究为ASFV亚单位疫苗的开发和细胞内蛋白的免疫原性提供了一种增强病毒衣壳蛋白折叠、多聚体结构形成和免疫原性的简单方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Infectious Diseases
ACS Infectious Diseases CHEMISTRY, MEDICINALINFECTIOUS DISEASES&nb-INFECTIOUS DISEASES
CiteScore
9.70
自引率
3.80%
发文量
213
期刊介绍: ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to: * Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials. * Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets. * Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance. * Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents. * Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota. * Small molecule vaccine adjuvants for infectious disease. * Viral and bacterial biochemistry and molecular biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信